Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)
|
June 13, 2022
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Francesca Pistollato, Anna Bal-Price, Sandra Coecke, et al.
Computational Toxicology (Amsterdam, Netherlands)
|
February 25, 2022
Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network
Nicoleta Spînu, Mark T D Cronin, Junpeng Lao, et al.
Advances in Experimental Medicine and Biology
|
September 28, 2016
Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing
Glyn N Stacey, Sandra Coecke, Anna-Bal Price, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 1, 2018
Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways
Daniel L Villeneuve, Brigitte Landesmann, Paola Allavena, et al.
ALTEX
|
April 27, 2018
Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
David Pamies, Anna Bal-Price, Christophe Chesné, et al.
Neurotoxicology
|
April 3, 2016
A multi-laboratory evaluation of microelectrode array-based measurements of neural network activity for acute neurotoxicity testing
Andrea Vassallo, Michela Chiappalone, Ricardo De Camargos Lopes, et al.
ALTEX
|
July 26, 2016
Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use
Michael Aschner, Sandra Ceccatelli, Mardas Daneshian, et al.
Critical Reviews in Toxicology
|
January 22, 2015
Putative adverse outcome pathways relevant to neurotoxicity
Anna Bal-Price, Kevin M Crofton, Magdalini Sachana, et al.
Environmental Health Perspectives
|
June 26, 2007
Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies
Sandra Coecke, Alan M Goldberg, Sandra Allen, et al.
Cells
|
November 11, 2022
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
Helena T Hogberg, Ann Lam, Elan Ohayon, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Reproductive Toxicology (Elmsford, N.Y.)
|
June 13, 2022
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Francesca Pistollato, Anna Bal-Price, Sandra Coecke, et al.
Computational Toxicology (Amsterdam, Netherlands)
|
February 25, 2022
Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network
Nicoleta Spînu, Mark T D Cronin, Junpeng Lao, et al.
Advances in Experimental Medicine and Biology
|
September 28, 2016
Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing
Glyn N Stacey, Sandra Coecke, Anna-Bal Price, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 1, 2018
Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways
Daniel L Villeneuve, Brigitte Landesmann, Paola Allavena, et al.
ALTEX
|
April 27, 2018
Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
David Pamies, Anna Bal-Price, Christophe Chesné, et al.
Neurotoxicology
|
April 3, 2016
A multi-laboratory evaluation of microelectrode array-based measurements of neural network activity for acute neurotoxicity testing
Andrea Vassallo, Michela Chiappalone, Ricardo De Camargos Lopes, et al.
ALTEX
|
July 26, 2016
Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use
Michael Aschner, Sandra Ceccatelli, Mardas Daneshian, et al.
Critical Reviews in Toxicology
|
January 22, 2015
Putative adverse outcome pathways relevant to neurotoxicity
Anna Bal-Price, Kevin M Crofton, Magdalini Sachana, et al.
Environmental Health Perspectives
|
June 26, 2007
Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies
Sandra Coecke, Alan M Goldberg, Sandra Allen, et al.
Cells
|
November 11, 2022
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
Helena T Hogberg, Ann Lam, Elan Ohayon, et al.
Page
of 8